DENG Yifang, YU Pengxia, HUANG Xiaoling, HE Xingdong, YIN Ming, LIU Minyu. Effects of p-hydroxyacetophenone on bile secretion and blood lipid levels in rats[J]. Journal of Pharmaceutical Practice and Service, 2016, 34(6): 507-510,525. doi: 10.3969/j.issn.1006-0111.2016.06.007
Citation:
|
DENG Yifang, YU Pengxia, HUANG Xiaoling, HE Xingdong, YIN Ming, LIU Minyu. Effects of p-hydroxyacetophenone on bile secretion and blood lipid levels in rats[J]. Journal of Pharmaceutical Practice and Service, 2016, 34(6): 507-510,525. doi: 10.3969/j.issn.1006-0111.2016.06.007
|
Effects of p-hydroxyacetophenone on bile secretion and blood lipid levels in rats
- 1.
China State Institute of Pharmaceutical Industry, Shanghai 201203 China
- 2.
School of Pharmacy, Shanghai Jiaotong University, Shanghai 200240, China
- Received Date: 2015-12-28
- Rev Recd Date:
2016-05-30
-
Abstract
Objective To study the effects and mechanism of p-hydroxyacetophenone (PHA) on bile secretion, cholesterol metabolism and blood lipids. Methods Cystic duct cannula was cannulated and bile were collected in SD rats.PHA was administrated in the high cholesterol rats. The activity of HMG-CoA reductase was determined by spectrophotometry in reaction system. Samples of liver were obtained in experiment hypercholesterolemia rats and Real-time PCR test was conducted for AQP8, CYP7A1, OATP and NTCP. Results Secretion of bile were increased, cholesterol in bile were reduced and secretion of total bile acid were increased in rats by PHA. The level of serum cholesterol in hyperglycemia rat model was reduced significantly and inhibitory ability had been limited in the activity of HMG-CoA reeducates by PHA, but the gene transcription including AQP8, CYP7A1, OATP, and NTCP were promoted, which are related to function of excretion of biliary acid and transformation of cholesterol. Conclusion These results suggest that PHA, as a lead compound, might be of significance for further development for a bile secretory and lipid lowering agent.
-
References
[1]
|
胡熙明,张文康,朱庆生,等.中华本草(第7册)[M].上海:上海科学技术出版社,1999:687-693. |
[2]
|
谢韬, 梁敬钰, 刘净. 茵陈化学成分和药理作用研究进展[J]. 海峡药学, 2004, 16(1):8-13. |
[3]
|
曹锦花.茵陈的化学成分和药理作用研究进展[J].沈阳药科大学学报,2013,30(6):489-494. |
[4]
|
董岩,王新芳,崔长军,等. 茵陈蒿的化学成分和药理作用研究进展[J]. 时珍国医国药, 2008, 19(04):874-876. |
[5]
|
Yoon M,Kim MY.The anti-angiogenic herbal composition Ob-X from Morus alba,Melissa officinalis, and Artemisia capillaris regulates obesity in genetically obese ob/ob mice[J]. Pham Biol,2011,49(6):614-619. |
[6]
|
向怀,覃薛文.茵陈清热利胆汤治疗妊娠期肝内胆汁淤积症30例总结[J].湖南中医杂志,2013,29(6):49-50. |
[7]
|
张林丽. 茵陈的药理研究和临床应用近况[J]. 广西医学,2003, 25(11):2184-2185. |
[8]
|
李佳佳,罗贞恋,覃川,等.茵陈蒿汤加味方对高脂血症小鼠血清总胆固醇和甘油三酯影响的实验研究[J].贵阳中医学院学报, 2014, 36(6):24-27. |
[9]
|
Richard A J, Fuller S, Fedocenco V, et al. Artemisia scoparia enhances adipocyte development and endocrine function in vitro and enhances insulin action in vivo[J]. PLoS ONE,2014, 9(6):e98897. |
[10]
|
王喜军,李廷利,孙晖.茵陈蒿汤及其血中移行成分6,7二甲氧基香豆素的肝保护作用[J].中国药理学通报,2004,20(2):239-240. |
[11]
|
阙金花,黄鸣清,郑海音,等. 复方熊胆茵陈颗粒的保肝、降血脂、抗脂肪肝药效学研究[J]. 中国医院药学杂志, 2015,35(19):1736-1740. |
[12]
|
Wang Z Q, Zhang X, Yu Y, et al. Artemisia scoparia extract attenuates non-alcoholic fatty liver disease in diet-induced obesity mice by enhancing hepatic insulin and AMPK signaling independently of FGF21 pathway[J].Metab Clin Exp, 2013, 62(9):1239-1249. |
-
-
Proportional views
-